All companies
Hims and Hers Health logo

What smart money is saying about Hims and Hers HealthUnited States flag

HIMS · Healthcare · Medical - Care Facilities · Market cap $6.62B

1 fund in our archive has pitched Hims and Hers Health — most recently Cedar Grove Capital Management Multi-Strategy Composite in September 2026.

Company profile

Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.

Get an email when a fund writes about it

Summarize with Warren AI
1
Reported positions
1
Bought
0
Sold
1
Letter

Position history

Every position in Hims and Hers Health on record in the archive was reported in Q3 2026, across 1 fund letter — 1 opened or added to the position.

Fund letters reporting a position in Hims and Hers Health, by quarter
QuarterLettersBoughtSoldTheses
Q3 20261101

Fund activity · 1 position · 1 move

  • “During the quarter, we increased our positions in Abivax (ABVX), Evolv Technologies (EVLV), Tantalus System Holding (GRID.TO), Hims and Hers Health (HIMS), Kits Eyecare (KITS.TO), LENSAR (LNSR), Nektar Therapeutics (NKTR), Hydreight Technologies (NURS.V), The RealReal (REAL), and Starling Oncology (STLN), formerly known as The Oncology Institute (TOI).”
    Hims and Hers Health

Fund coverage · 1 thesis

Read every full thesis on Hims and Hers Health

Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.

View plans→
Share this ledger